204 related articles for article (PubMed ID: 1964663)
1. Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis.
Harenberg J; Huck K; Bratsch H; Stehle G; Dempfle CE; Mall K; Blauth M; Usadel KH; Heene DL
Haemostasis; 1990; 20 Suppl 1():205-19. PubMed ID: 1964663
[TBL] [Abstract][Full Text] [Related]
2. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Cziraky MJ; Spinler SA
Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
[TBL] [Abstract][Full Text] [Related]
5. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
[TBL] [Abstract][Full Text] [Related]
7. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Harenberg J; Roebruck P; Heene DL
Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
[TBL] [Abstract][Full Text] [Related]
9. Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.
Bara L; Leizorovicz A; Picolet H; Samama M
Thromb Res; 1992 Mar; 65(4-5):641-50. PubMed ID: 1319619
[TBL] [Abstract][Full Text] [Related]
10. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
[TBL] [Abstract][Full Text] [Related]
11. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
Lopaciuk S; Meissner AJ; Filipecki S; Zawilska K; Sowier J; Ciesielski L; Bielawiec M; Glowinski S; Czestochowska E
Thromb Haemost; 1992 Jul; 68(1):14-8. PubMed ID: 1325076
[TBL] [Abstract][Full Text] [Related]
13. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
Fiessinger JN; Lopez-Fernandez M; Gatterer E; Granqvist S; Kher A; Olsson CG; Söderberg K
Thromb Haemost; 1996 Aug; 76(2):195-9. PubMed ID: 8865530
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
Krauss T; Rath W; Dittmer U; Kuhn W
Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
Kearon C; Ginsberg JS; Julian JA; Douketis J; Solymoss S; Ockelford P; Jackson S; Turpie AG; MacKinnon B; Hirsh J; Gent M;
JAMA; 2006 Aug; 296(8):935-42. PubMed ID: 16926353
[TBL] [Abstract][Full Text] [Related]
18. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S;
Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis.
Lindmarker P; Holmström M; Granqvist S; Johnsson H; Lockner D
Thromb Haemost; 1994 Aug; 72(2):186-90. PubMed ID: 7831649
[TBL] [Abstract][Full Text] [Related]
20. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study.
Thromb Haemost; 1991 Mar; 65(3):251-6. PubMed ID: 1646490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
